Loading clinical trials...
Loading clinical trials...
A Multicenter, Double-Blind, Placebo-Controlled, Phase III Clinical Trial Evaluating Megestrol Acetate for the Management of Fatigue in Advanced Breast Cancer Patients Treatment With Trastuzumab Deruxtecan
Conditions
Interventions
Megestrol Acetate + Trastuzumab Deruxtecan
Placebo + Trastuzumab Deruxtecan
Locations
1
China
Sun yat-Sen University Cancer Center
Guangzhou, Yuexiu District, China
Start Date
May 1, 2026
Primary Completion Date
April 1, 2029
Completion Date
April 1, 2031
Last Updated
April 22, 2026
Lead Sponsor
Sun Yat-sen University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions